Association of a functional polymorphism in the 3'-untranslated region of SPI1 with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 63, Issue 3, 2011, Pages 755-763

  Hikami, Koki ^a   Kawasaki, Aya ^a   Ito, Ikue ^a   Koga, Minori ^a   Ito, Satoshi ^a,b   Hayashi, Taichi ^a   Matsumoto, Isao ^a   Tsutsumi, Akito ^a,c   Kusaoi, Makio ^d   Takasaki, Yoshinari ^d   Hashimoto, Hiroshi ^d   Arinami, Tadao ^a   Sumida, Takayuki ^a   Tsuchiya, Naoyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Niigata Rheumatic Center   (Japan)

^c KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE CONTROL STUDY; DATA BASE; DISEASE PREDISPOSITION; EXON; FEMALE; GENETIC LINKAGE; GENETIC TRANSFECTION; GENOTYPE; HUMAN; INTRON; JAPANESE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

3' UNTRANSLATED REGIONS; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, REPORTER; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RISK FACTORS; TRANS-ACTIVATORS; TRANSFECTION; YOUNG ADULT;

EID: 79953721951     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30188     Document Type: Article

References (48)

1. Horn G, Graham RR, Modrek B, Taylor KE, Ortmann W, Gamier S, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008;358:900-9. (Pubitemid 351397089)
2. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008;40:204-10. (Pubitemid 351171405)
3. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009;41:1234-7.
4. Kyogoku C, Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 2007;8: 445-55. (Pubitemid 47365611)
5. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003;100:2610-5. (Pubitemid 36297546)
6. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-23. (Pubitemid 36350866)
7. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 2003;4:177-86. (Pubitemid 38967595)
8. Kawasaki A, Kyogoku C, Ohashi J, Miyashita R, Hikami K, Kusaoi M, et al. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum 2008;58:826-34. (Pubitemid 351364880)
9. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 2007;104:6758-63. (Pubitemid 47175574)
10. Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK. Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients. Arthritis Rheum 2008;58:2481-7.
11. Sigurdsson S, Goring HH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 2008;17:872-81. (Pubitemid 351368993)
12. DeKoter RP, Walsh JC, Singh H. PU.1 regulates both cytokinedependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J 1998;17:4456-68. (Pubitemid 28362634)
13. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med 2005;201:1487-502. (Pubitemid 40664092)
14. Dakic A, Wu L, Nutt SL. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol 2007;28:108-14. (Pubitemid 46283693)
15. Kastner P, Chan S. PU.1: a crucial and versatile player in hematopoiesis and leukemia. Int J Biochem Cell Biol 2008;40: 22-7. (Pubitemid 350052657)
16. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 2004;36:624-30. (Pubitemid 38715991)
17. Metcalf D, Dakic A, Mifsud S, Di Rago L, Wu L, Nutt S. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc Natl Acad Sci U S A 2006;103:1486-91. (Pubitemid 43191192)
18. Okuno Y, Huang G, Rosenbauer F, Evans EK, Radomska HS, Iwasaki H, et al. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Mol Cell Biol 2005;25: 2832-45. (Pubitemid 40381644)
19. Rosenbauer F, Owens BM, Yu L, Tumang JR, Steidl U, Kutok JL, et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat Genet 2006;38:27-37. (Pubitemid 43011879)
20. Ebralidze AK, Guibal FC, Steidl U, Zhang P, Lee S, BartholdyB, et al. PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev 2008;22:2085-92.
21. Yee AA, Yin P, Siderovski DP, Mak TW, Litchfield DW, Arrowsmith CH. Cooperative interaction between the DNA-binding domains of PU.1 and IRF4. J Mol Biol 1998;279:1075-83. (Pubitemid 28302385)
22. Huang W, Horvath E, Eklund EA. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells. J Biol Chem 2007;282:6629-43. (Pubitemid 47100819)
23. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010;20:170-9.
24. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
25. Ohashi J, Yamamoto S, Tsuchiya N, Hatta Y, Komata T, Matsushita M, et al. Comparison of statistical power between 2 X 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann Hum Genet 2001;65:197-206. (Pubitemid 32452121)
26. Ito I, Kawaguchi Y, Kawasaki A, Hasegawa M, Ohashi J, Hikami K, et al. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis Rheum 2009;60:1845-50.
27. Steidl U, Steidl C, Ebralidze A, Chapuy B, Han HJ, Will B, et al. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J Clin Invest 2007;117:2611-20. (Pubitemid 47494362)
28. Taylor KE, Remmers EF, Lee AT, Ortmann WA, Plenge RM, Tian C, et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008;4:e1000084.
29. Bates JS, Lessard CJ, Leon JM, Nguyen T, Battiest LJ, Rodgers J, et al. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun 2009;10:470-7.
30. Yang W, Shen N, Ye DQ, Liu Q, Zhang Y, Qian XX, et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 2010;6:e1000841.
31. Back J, Allman D, Chan S, Kastner P. Visualizing PU.1 activity during hematopoiesis. Exp Hematol 2005;33:395-402. (Pubitemid 40387621)
32. Nutt SL, Metcalf D, D'Amico A, Polli M, Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J Exp Med 2005;201:221-31. (Pubitemid 40189431)
33. Zhang DE, Hetherington CJ, Chen HM, Tenen DG. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 1994;14:373-81.
34. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang DE, Tenen DG. PU.1 (Spi-1) and C/EBPα regulate expression of the granulocytemacrophage colony-stimulating factor receptor α gene. Mol Cell Biol 1995;15:5830-45.
35. DeKoter RP, Lee HJ, Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 2002;16: 297-309. (Pubitemid 34211968)
36. Nutt SL, Kee BL. The transcriptional regulation of B cell lineage commitment. Immunity 2007;26:715-25. (Pubitemid 46908962)
37. McDevit DC, Perkins L, Atchison ML, Nikolajczyk BS. The Igk3' enhancer is activated by gradients of chromatin accessibility and protein association. J Immunol 2005;174:2834-42. (Pubitemid 40279700)
38. Yoon H, Boss JM. PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA. J Immunol 2010;184:5018-28.
39. Green MR, Yoon H, Boss JM. Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility. J Immunol 2006;177:3865-73. (Pubitemid 44359921)
40. Joo M, Kwon M, Azim AC, Sadikot RT, Blackwell TS, Christman JW. Genetic determination of the role of PU.1 in macrophage gene expression. Biochem Biophys Res Commun 2008;372:97-102.
41. Azim AC, Wang X, Park GY, Sadikot RT, Cao H, Mathew B, et al. NF-kB-inducing kinase regulates cyclooxygenase 2 gene expression in macrophages by phosphorylation of PU.1. J Immunol 2007;179:7868-75.
42. Unlu S, Kumar A, Waterman WR, Tsukada J, Wang KZ, Galson DL, et al. Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B gene. Mol Immunol 2007;44:3364-79. (Pubitemid 46678199)
43. Tsujimura H, Tamura T, Kong HJ, Nishiyama A, Ishii KJ, Klinman DM, et al. Toll-like receptor 9 signaling activates NF-kB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J Immunol 2004;172:6820-7. (Pubitemid 38669120)
44. Tailor P, Tamura T, Kong HJ, Kubota T, Kubota M, Borghi P, et al. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007;27: 228-39. (Pubitemid 47284921)
45. Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008;40:211-26.
46. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009;41:1228-33.
47. Tian C, Kosoy R, Lee A, Ransom M, Belmont JW, Gregersen PK, et al. Analysis of East Asia genetic substructure using genomewide SNP arrays. PLoS One 2008;3:e3862.
48. Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A 2010;107:15838-43.